A detailed history of Squarepoint Ops LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 7,490 shares of HRMY stock, worth $255,109. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,490
Previous 50,017 85.03%
Holding current value
$255,109
Previous $1.51 Million 80.19%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.0 - $39.95 $1.28 Million - $1.7 Million
-42,527 Reduced 85.03%
7,490 $299,000
Q2 2024

Aug 14, 2024

BUY
$28.81 - $33.01 $1.44 Million - $1.65 Million
50,017 New
50,017 $1.51 Million
Q1 2023

May 15, 2023

SELL
$30.8 - $53.92 $1.87 Million - $3.27 Million
-60,623 Reduced 77.76%
17,339 $566,000
Q4 2022

Feb 14, 2023

BUY
$45.4 - $60.91 $1.4 Million - $1.87 Million
30,783 Added 65.25%
77,962 $4.3 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $467,370 - $616,160
11,112 Added 30.81%
47,179 $2.09 Million
Q2 2022

Aug 15, 2022

SELL
$33.54 - $52.15 $466,340 - $725,093
-13,904 Reduced 27.82%
36,067 $1.76 Million
Q1 2022

May 16, 2022

BUY
$33.14 - $51.13 $355,260 - $548,113
10,720 Added 27.31%
49,971 $2.43 Million
Q4 2021

Feb 14, 2022

BUY
$34.09 - $43.91 $1.34 Million - $1.72 Million
39,251 New
39,251 $1.67 Million
Q3 2021

Nov 15, 2021

SELL
$25.68 - $38.61 $976,892 - $1.47 Million
-38,041 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$25.96 - $33.44 $987,544 - $1.27 Million
38,041 New
38,041 $1.07 Million
Q4 2020

Feb 16, 2021

SELL
$31.74 - $51.34 $332,032 - $537,067
-10,461 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$30.96 - $44.39 $323,872 - $464,363
10,461 New
10,461 $355,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.